CDNA
CareDx, IncNASDAQHealthcare$18.31+2.46%ClosedMarket Cap: $941.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.09
P/S
2.48
EV/EBITDA
-7466.51
DCF Value
$-11.24
FCF Yield
3.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.2%
Operating Margin
-7.5%
Net Margin
-5.6%
ROE
-6.5%
ROA
-6.3%
ROIC
-8.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $108.4M | 66.6% | $-5.9M | $-4.1M | $-0.08 | — |
| FY 2025 | $379.8M | 67.0% | $-21.0M | $-21.4M | $-0.40 | — |
| Q3 2025 | $100.1M | 68.7% | $2.0M | $1.7M | $0.03 | — |
| Q2 2025 | $86.7M | 66.9% | $-11.1M | $-8.6M | $-0.16 | — |
| Q1 2025 | $84.7M | 66.4% | $-13.4M | $-10.4M | $-0.19 | — |
| Q4 2024 | $86.6M | 67.5% | $74.7M | $78.0M | $1.51 | — |
| FY 2024 | $333.8M | 67.2% | $40.8M | $52.5M | $0.93 | — |
| Q3 2024 | $82.9M | 66.7% | $-10.5M | $-7.4M | $-0.14 | — |
| Q2 2024 | $92.3M | 69.7% | $-7.3M | $-4.6M | $-0.09 | — |
| Q1 2024 | $72.0M | 64.0% | $-19.3M | $-16.7M | $-0.38 | — |
| Q4 2023 | $65.6M | 60.9% | $-122.6M | $-118.1M | $-2.24 | — |
| FY 2023 | $280.3M | 63.6% | $-203.4M | $-190.3M | $-3.54 | — |